Antibody-dependent effector functions against HIV decline in subjects receiving antiretroviral therapy.
about
NK Cells in HIV DiseaseAntiviral Functions of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific IgG Antibodies: Effects of Antiretroviral Therapy and Implications for Therapeutic HIV-1 Vaccine Design.HIV-Specific Antibody-Dependent Cellular Cytotoxicity (ADCC) -Mediating Antibodies Decline while NK Cell Function Increases during Antiretroviral Therapy (ART).Enhanced FCGR2A and FCGR3A signaling by HIV viremic controller IgG.Can HIV-1-Specific ADCC Assist the Clearance of Reactivated Latently Infected Cells?HIV-1 Env- and Vpu-Specific Antibody-Dependent Cellular Cytotoxicity Responses Associated with Elite Control of HIV.Antibody-Dependent Cellular Cytotoxicity against Reactivated HIV-1-Infected Cells.Anti-HIV-1 ADCC Antibodies following Latency Reversal and Treatment Interruption.Natural Killer cells in HIV-1 infection and therapy.AS03-adjuvanted H5N1 vaccine promotes antibody diversity and affinity maturation, NAI titers, cross-clade H5N1 neutralization, but not H1N1 cross-subtype neutralization
P2860
Q26752833-DDDCF543-206D-4719-9F0F-7CE5CF3EF39FQ33867299-F05FF627-1347-4A33-B8EF-7BAF11E46DF5Q35876207-80EBE7D7-EC2E-46F5-92E5-4A4B86ADB512Q37646897-1E5C1188-56F8-4D0E-8913-657E0A97143AQ38527822-2C784D5A-841F-4D56-B9FE-1177080DA682Q38682077-7CB795A4-77B9-4EF3-A879-862E8F730C84Q38812544-06129C49-FD6C-40F1-A8DE-7D8961090A0BQ40187580-831F05D8-8AE2-4647-8FA5-7C147EBCC7F1Q41934634-5E8A0D72-96AA-4586-8D38-F9AA96CC6999Q57299518-25BD6E23-E475-4DEE-A909-50705E88F0A3
P2860
Antibody-dependent effector functions against HIV decline in subjects receiving antiretroviral therapy.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Antibody-dependent effector fu ...... eiving antiretroviral therapy.
@en
Antibody-dependent effector fu ...... eiving antiretroviral therapy.
@nl
type
label
Antibody-dependent effector fu ...... eiving antiretroviral therapy.
@en
Antibody-dependent effector fu ...... eiving antiretroviral therapy.
@nl
prefLabel
Antibody-dependent effector fu ...... eiving antiretroviral therapy.
@en
Antibody-dependent effector fu ...... eiving antiretroviral therapy.
@nl
P2093
P2860
P50
P356
P1476
Antibody-dependent effector fu ...... eiving antiretroviral therapy.
@en
P2093
Anthony D Kelleher
David A Cooper
Denise Hsu
Fernanda E Ana-Sosa-Batiz
Ivan Stratov
Marit Kramski
Matthew S Parsons
Rob J Center
Sarah Pett
Sinthujan Jegaskanda
P2860
P304
P356
10.1093/INFDIS/JIU486
P407
P577
2014-08-28T00:00:00Z